Page last updated: 2024-08-23

cetylpyridinium chloride anhydrous and Graft vs Host Disease

cetylpyridinium chloride anhydrous has been researched along with Graft vs Host Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bergkvist, K; Johansson, E; Johansson, UB; Larsen, J; Mattsson, J; Remberger, M; Svahn, BM; Winterling, J1

Other Studies

1 other study(ies) available for cetylpyridinium chloride anhydrous and Graft vs Host Disease

ArticleYear
General health, symptom occurrence, and self-efficacy in adult survivors after allogeneic hematopoietic stem cell transplantation: a cross-sectional comparison between hospital care and home care.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2015, Volume: 23, Issue:5

    Topics: Adult; Aged; Cross-Sectional Studies; Female; Graft vs Host Disease; Health; Hematopoietic Stem Cell Transplantation; Home Care Services; Hospitalization; Humans; Leukemia; Male; Middle Aged; Self Care; Self Efficacy; Surveys and Questionnaires; Survivors; Young Adult

2015